Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome

January 20, 2016- Produced, Interviewed by Steven E. Greer, MD

We interviewed Anthony Lembo, MD of The Beth Israel Deaconess Hospital to discuss his NEJM paper on the results of two clinical trials that studied Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome.

This entry was posted in - NEJM, - Pharma, Gastroenterology and liver, Harvard. Bookmark the permalink.

Leave a Reply